Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.6 (
thromboplastin
)
13,278
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
At sites of vascular injury thrombin is generated via
prothrombinase
, a stoichiometric (1:1), Ca2+-dependent, and membrane-bound complex consisting of the nonenzymatic cofactor factor Va and the serine protease
factor Xa
. While the importance of anionic platelet membrane phospholipids in regulating thrombin generation is well recognized, the identification of regulatory protein receptors has eluded investigators. This study reports the first description of a human platelet membrane protein that regulates
prothrombinase
complex assembly and function. Direct platelet-protein binding studies indicated that, although required, platelet-bound factor Va alone is insufficient to mediate
factor Xa
binding, and that factor Va and
factor Xa
bind to discrete sites on activated platelets for which expression is independently regulated as a function of the agonist concentration. When specific monoclonal antibodies against effector cell protease receptor-1 (
EPR-1
, a 65-kDa membrane receptor for
factor Xa
) were used in Western blotting, immunohistochemical staining, and/or flow cytometric analyses, activated platelets and their precursors, megakaryocytes, were shown to express
EPR-1
. These results were confirmed by reverse transcription-polymerase chain reaction of mRNA extracted from megakaryocyte-like cell lines. Additional flow cytometric studies demonstrated that a platelet-bound factor Va/
factor Xa
complex precluded binding of the anti-
EPR-1
antibody, B6, to activated platelets by approximately 50%. Likewise, the anti-
EPR-1
antibody was shown to inhibit
prothrombinase
-catalyzed thrombin generation on activated platelets in a dose- and platelet donor-dependent manner, indicating that platelet-expressed
EPR-1
mediates
factor Xa
assembly into the
prothrombinase
complex. These collective data indicate that both
EPR-1
and membrane-bound factor Va are required to mediate
factor Xa
binding to the activated platelet to form a functional
prothrombinase
complex.
...
PMID:Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. 908 58
In addition to its pivotal role in hemostasis,
factor Xa
binds to human umbilical vein endothelial cells through the recognition of a protein called effector cell protease receptor (
EPR-1
). This interaction is associated with signal transduction, generation of intracellular second messengers, and modulation of cytokine gene expression. Inhibitors of
factor Xa
catalytic activity block these responses, thus indicating that the
factor Xa
-dependent event of local proteolysis is absolutely required for cell activation. Because
EPR-1
does not contain proteolysis-sensitive sites, we investigated the possibility that signal transduction by
factor Xa
requires proteolytic activation of a member of the protease-activated receptor (PAR) gene family. Catalytic inactivation of
factor Xa
by DX9065 suppressed
factor Xa
-induced increase in cytosolic free Ca(2+) in endothelial cells (IC(50)=0.23 micromol/L) but failed to reduce ligand binding to
EPR-1
. In desensitization experiments, trypsin or the PAR-2-specific activator peptide, SLIGKV, ablated the Ca(2+) signaling response induced by
factor Xa
. Conversely, pretreatment of endothelial cells with
factor Xa
blocked the PAR-2-dependent increase in cytosolic Ca(2+) signaling, whereas PAR-1-dependent responses were unaffected. Direct cleavage of PAR-2 by
factor Xa
on endothelial cells was demonstrated by cleavage of a synthetic peptide duplicating the PAR-2 cleavage site and by immunofluorescence with an antibody to a peptide containing the 40-amino acid PAR-2 extracellular extension. These data suggest that
factor Xa
induces endothelial cell activation via a novel cascade of receptor activation involving docking to
EPR-1
and local proteolytic cleavage of PAR-2.
...
PMID:Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2. 1107 63
Blood coagulation plays a key role among numerous mediating systems that are activated in inflammation. Receptors of the PAR family serve as sensors of serine proteinases of the blood clotting system in the target cells involved in inflammation. Activation of PAR-1 by thrombin and of PAR-2 by
factor Xa
leads to a rapid expression and exposure on the membrane of endothelial cells of both adhesive proteins that mediate an acute inflammatory reaction and of the tissue factor that initiates the blood coagulation cascade. Certain other receptors (
EPR-1
, thrombomodulin, etc.), which can modulate responses of the cells activated by proteinases through PAR receptors, are also involved in the association of coagulation and inflammation together with the receptors of the PAR family. The presence of PAR receptors on mast cells is responsible for their reactivity to thrombin and
factor Xa
and defines their contribution to the association of inflammation and blood clotting processes.
...
PMID:Receptors of the PAR family as a link between blood coagulation and inflammation. 1184 41